Lineage Cell Therapeutics, Inc. Share Price
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
01:21:35 21/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.075 USD | -2.27% |
|
+1.42% | -35.63% |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 07/08 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 28Cr 24Cr 22Cr 20Cr 38Cr 2.66TCr 39Cr 263.65Cr 102.77Cr 1.33TCr 104.46Cr 102.18Cr 4.42TCr | P/E 2026 * |
-16.4x | P/E 2027 * | -10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 28Cr 24Cr 22Cr 20Cr 38Cr 2.66TCr 39Cr 263.65Cr 102.77Cr 1.33TCr 104.46Cr 102.18Cr 4.42TCr | EV / Sales 2026 * |
18.3x | EV / Sales 2027 * | 16.5x |
| Free-Float |
95.14% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 day | -2.27% | ||
| 1 week | +1.42% | ||
| Current month | -0.46% | ||
| 1 month | -2.27% | ||
| 3 months | -16.67% | ||
| 6 months | -40.61% | ||
| Current year | -35.63% |
| 1 week | 1.04 |  | 1.13 |
| 1 month | 1 | | 1.18 |
| Current year | 1 | | 1.98 |
| 1 year | 1 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.8 |
| 10 years | 0.37 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 17/09/2018 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 14/11/2022 |
| Chief Operating Officer | - | 01/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 01/07/2009 |
Deborah Andrews
BRD | Director/Board Member | 68 | 11/04/2014 |
Michael Mulroy
CHM | Chairman | 60 | 27/04/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Free | Director | 1,25,000 | 0.0501% | ||
| 01/07/26 | Broadwood Capital, Inc.
| Free | Company | 1,25,000 | 0.0501% | |
| 01/07/26 | Free | Director | 1,25,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.27% | +1.42% | -9.66% | -21.53% | 28Cr | |
| +1.14% | +2.27% | +2.38% | +24.66% | 5.05TCr | |
| -1.74% | +4.94% | +486.23% | +609.68% | 4.6TCr | |
| -2.06% | +4.17% | +19.89% | +89.10% | 4.28TCr | |
| +3.14% | +7.01% | +34.59% | +20.57% | 4.1TCr | |
| 0.00% | -3.91% | +17.87% | +47.98% | 3.2TCr | |
| +1.23% | +5.86% | +32.27% | +150.44% | 1.7TCr | |
| -2.16% | +4.11% | - | - | 1.71TCr | |
| +3.06% | +4.63% | +7.40% | +35.00% | 1.43TCr | |
| +0.90% | +4.49% | +84.16% | +46.28% | 1.38TCr | |
| Average | +0.14% | +2.41% | +75.01% | +111.35% | 2.75TCr | |
| Weighted average by Cap. | +0.26% | +2.71% | +105.31% | +151.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.52Cr 1.3Cr 1.21Cr 1.11Cr 2.09Cr 145.37Cr 2.13Cr 14Cr 5.61Cr 73Cr 5.7Cr 5.58Cr 241.2Cr | 1.68Cr 1.44Cr 1.34Cr 1.23Cr 2.32Cr 161.08Cr 2.36Cr 16Cr 6.22Cr 81Cr 6.32Cr 6.18Cr 267.26Cr |
| Net income | -2.26Cr -1.94Cr -1.81Cr -1.66Cr -3.12Cr -216.63Cr -3.18Cr -21Cr -8.36Cr -108.57Cr -8.5Cr -8.32Cr -359.43Cr | -3.44Cr -2.95Cr -2.75Cr -2.52Cr -4.74Cr -329.54Cr -4.84Cr -33Cr -13Cr -165.15Cr -13Cr -13Cr -546.76Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | $1.075 | -2.27% | 8,65,370 |
| 19/26/19 | $1.100 | +3.77% | 9,51,490 |
| 18/26/18 | $1.060 | 0.00% | 11,12,362 |
| 17/26/17 | $1.060 | -0.93% | 7,95,388 |
| 14/26/14 | $1.070 | +0.94% | 11,29,385 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
